Sarah Ford | February 9, 2015
Research progress report: Frizzled 9 and lung cancer chemoprevention
Every year, lung cancer leads to more deaths than any other cancer. An estimated 159,2601Â Americans were expected to die from lung cancer in 2014, accounting for about 27% of all cancer deaths.
The Foundation is committed to lung cancer prevention research and currently supports five researchers studying different aspects of preventing this deadly disease. One of these researchers is Meredith Tennis, Ph.D., of the University of Colorado Denver. Her project focuses on Frizzled 9, a protein that helps to maintain normal lung tissue, as a potential biomarker2Â to predict how patients may respond to the drug iloprost, a drug being used for chemoprevention.
Get Resources and Insights Straight To Your Inbox
Explore More Articles
Micro-Influencers and Nonprofits: Local Partnerships
What does your nonprofit’s digital presence look like these days? Having a website and social media accounts almost goes without saying, and your team likely…
Why Your Company Should Offer a Matching Gift Program
Every year, billions of dollars in potential charitable giving go unclaimed, not because employees don’t want to give, but because their employers haven’t made it…
Employee Disaster Relief: How to Build an Emergency Assistance Fund Before the Next Crisis
The 2026 hurricane season is already underway. While NOAA forecasts a 55% probability of a below-average season, projections still call for 8–14 named storms, 3–6…
Get Resources and Insights Straight To Your Inbox
Receive our monthly/bi-monthly newsletter filled with information about causes, nonprofit impact, and topics important for corporate social responsibility and employee engagement professionals, including disaster response, workplace giving, matching gifts, employee assistance funds, volunteering, scholarship award program management, grantmaking, and other philanthropic initiatives.
